Loading data
CXMNYSE
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 857.2 m USD | 796.39 m USD | 732.36 m USD | 618.19 m USD | 492.39 m USD |
| Cost of revenue | 279.42 m USD | 221.76 m USD | 179.4 m USD | 163.73 m USD | 147.55 m USD |
| Gross profit | 577.78 m USD | 574.64 m USD | 552.96 m USD | 454.47 m USD | 344.84 m USD |
| Research and development expense | 96 m USD | 91.62 m USD | 91.29 m USD | 76.66 m USD | 60.59 m USD |
| Operating profit | 40.24 m USD | 23.97 m USD | 33.95 m USD | -51.22 m USD | -99.47 m USD |
| Profit before tax | 66.79 m USD | 48.29 m USD | 60.52 m USD | -47.47 m USD | -104.55 m USD |
| Income tax expense | 43.88 m USD | -73.32 m USD | 9.12 m USD | 8.27 m USD | 6.92 m USD |
| Net income (reported basis) | 22.91 m USD | 121.61 m USD | 51.4 m USD | -55.74 m USD | -111.47 m USD |
| Net income attributable to common shareholders | — | — | — | -55.74 m USD | -111.47 m USD |
| Basic earnings per share | 0.09 USD/share | 0.47 USD/share | 0.19 USD/share | -0.21 USD/share | -0.57 USD/share |
| Diluted earnings per share | 0.09 USD/share | 0.44 USD/share | 0.18 USD/share | -0.21 USD/share | -0.57 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.